Immunoreactivity of p53, PSA and bcl-2 in amniotic fluid smears from the second trimester of pregnancy.
Athanassiadou
Pauline
P
Gonidi
Maria
M
Liossi
Anna
A
Nakopoulou
Lydia
L
Petrakakou
Efthalia
E
Sakellariou
Vassiliki
V
Antsaklis
Aris
A
D000328:Adult; D000653:Amniotic Fluid / Q000276:immunology / Q000378:metabolism*; D002869:Chromosome Aberrations / Q000196:embryology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D011247:Pregnancy; D011262:Pregnancy Trimester, Second / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D011296:Prenatal Diagnosis; D017430:Prostate-Specific Antigen / Q000032:analysis* / Q000276:immunology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis* / Q000276:immunology; D016159:Tumor Suppressor Protein p53 / Q000032:analysis* / Q000276:immunology
D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53; D017430:Prostate-Specific Antigen